| IPO Date | June 18, 2026 to June 22, 2026 |
| Listing Date | June 25, 2026 |
| Face Value | ₹ 10 / Share |
| Price Band | ₹ 196 to ₹ 208 / Share |
| Lot Size | 600 Shares |
| Total Issue Size | 1453800 (Aggregating up to 30 ) |
| Fresh Issue | 1371600 (Aggregating up to 29 ) |
| Offer for Sale | |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share holding pre issue | 4031256 |
| Share holding post issue | 5485056 |
| Market Maker portion |
Avience Biomedicals IPO opens on June 18, 2026, and closes on June 22, 2026.
| IPO Open Date | June 18, 2026 |
| IPO Close Date | June 22, 2026 |
| Basis of Allotment | June 23, 2026 |
| Initiation of Refunds | June 25, 2026 |
| Credit of Shares to Demat | June 24, 2026 |
| Listing Date | June 25, 2026 |
| Cut-off time for UPI mandate confirmation | -- |
Investors can bid for a minimum of 1,200 shares and in multiples of 600 shares thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 1,200 | Rs.249,600 |
| Retail (Max) | 2 | 1,200 | Rs.249,600 |
| S-HNI (Min) | 3 | 1,800 | Rs.374,400 |
| S-HNI (Max) | 8 | 4,800 | Rs.998,400 |
| B-HNI (Min) | 9 | 5,400 | Rs.1,123,200 |
| HNI (Min) |
| Share Holding Pre Issue | 4031256 |
| Share Holding Post Issue | 5485056 |
Avience Biomedicals IPO comprises a total issue size of 14,53,800 shares. The net offer to the public is 13,71,600 shares, after excluding 82,200 shares allotted on a firm basis. Of the Net offer 6,83,400 (49.83%) are allocated to QIB, 2,07,000 (15.09%) allocated to NII 4,81,200 (35.08%) allocated to RII.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 409800 |
28.19 |
| Market Maker Shares Offered | 82200 |
5.65 |
| Other Shares Offered | |
|
| QIB Shares Offered | 683400 49.83 |
47.01 |
| NII (HNI) Shares Offered | 207000 15.09 |
14.24 |
| bNII > ₹10L | 138000 |
9.49 |
| sNII < ₹10L | 69000 |
4.75 |
| Retail Shares Offered | 481200 35.08 |
33.10 |
| Employee Shares Offered | |
|
| Total Shares Offered | 1453800 100.00 |
| Bid Date | 2026-06-17 |
| Shares Offered | 409800 |
| Anchor Portion Size (In Cr.) | 8.52 |
| Anchor lock-in period end date for 50% shares (30 Days) | July 23, 2026 |
| Anchor lock-in period end date for remaining shares (90 Days) | September 21, 2026 |
Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry.
Avience Biomedicals Limited has expanded its product range from IVD rapid test kits to a comprehensive line of medical devices, including serology products and biochemistry analyzers. This demonstrates a commitment to diverse healthcare needs, focusing exclusively on the B2B and B2G markets.
The company's products cater to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas.
In addition to manufacturing, the Company also act as distributors and traders of medical equipment.
The company's manufacturing unit is situated in Noida, Uttar Pradesh.
The company offers a comprehensive range of diagnostic solutions, including:
As of January 31, 2026, the company had 75 permanent employees and 33 contractual employees
Competitive Strength
| KPI | Values |
|---|---|
| ROE | 22.38 |
| ROCE | 16.99 |
| Debt/Equity | 0.94 |
| RoNW | 22.38 |
| P/BV | 2.94 |
| PAT Margin (%) | 15.86 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 17.94 | 12.56 |
| P/E (x) | 11.59 | 16.56 |
Dharam Deo Choudhary, Ram Nagina Choudhary, Janardan Pal and Deepa Choudhary
Avience Biomedicals Ltd. Address C-11, Block-C Community Centre Janakpuri A-3 Delhi, New Delhi, 110058
|